# To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

> **NCT02490774** · PHASE2 · TERMINATED · sponsor: **Bayer** · enrollment: 174 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** BAY1007626
- **DRUG:** Jaydess
- **DRUG:** Mirena

## Key facts

- **NCT ID:** NCT02490774
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06-22
- **Primary completion:** 2016-05-26
- **Final completion:** 2016-07-22
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02490774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02490774, "To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02490774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*